Tags

Type your tag names separated by a space and hit enter

Sex Differences in Pitch Range and Speech Fundamental Frequency After Arytenoid Adduction and Thyroplasty.
J Voice. 2016 May; 30(3):362-70.JV

Abstract

OBJECTIVE

The purpose of this study was to clarify the sex differences in pitch range (PR) and speech fundamental frequency (SFF) after arytenoid adduction (AA) combined with type 1 thyroplasty (TP1) in patients with unilateral vocal fold paralysis (UVFP) and to assess the cause of these differences.

STUDY DESIGN

This is a retrospective review of clinical records.

METHODS

The records of 50 patients with UVFP for whom PR, SFF, and maximum phonation time (MPT) had been evaluated before and 1 year after AA combined with TP1 were analyzed. Patients consisted of 36 men and 14 women. In particular, in the 37 patients (24 men and 13 women) who had ≥2 semitones (STs) in preoperative PR (pre-PR), the differences and correlations between the pre-PR and the postoperative PR (post-PR), SFF, and MPT were compared between the sexes. We also discussed cases of post-PR deterioration and abnormal SFF.

RESULTS

The characteristics of PR in men are narrow pre-PR (14.7 ± 11.5 STs) and significant extension of post-PR (22.6 ± 6.3 STs). MPT extended from 4.6 ± 2.5 seconds to 14.8 ± 7.2 seconds. In contrast, women had a wide pre-PR (18.1 ± 7.2 STs) and showed no significant post-PR extension (21.7 ± 7.8 STs). MPT extended from 5.1 ± 1.9 seconds to 16.8 ± 7.2 seconds. Although there were no significant changes in average SFF, as well as the highest and lowest pitch after the operation, the variance of the pre-SFF tended to converge into the physiological range in the post-SFF (P = 0.08). Compared with the SFF data of normal adult controls, post-SFF in the normal range was 46.0% (23/50). In patients who showed a >20% improvement in PR, normal post-SFF appeared in 68.8% of the patients (11/16). Particularly in those women, 83.3% (5/6) showed a normal post-SFF. Men showed greater difficulty in recovery of normal PR, SFF, and MPT; however, there were fewer patients (4.2%; 1/24) with a PR deterioration of >20%. Regarding women, although some patients showed a parallel recovery in PR and SFF to the normal range, there was a high rate of patients showing PR deterioration (30.8%; 4/13).

CONCLUSIONS

AA combined with TP1 resulted in the recovery of not only MPT but also PR and SFF. In addition, sex differences in operative effects were suggested. In men, although MPT is difficult to be fully recovered, PR deterioration was mild. In women, although MPT was more easily extended, PR deterioration occurred more readily because of operative effects such as hypermedialization of their smaller larynx. The post-PR variation appeared to be associated with SFF. Our results indicate the necessity to assess patients' PR and SFF even if their MPTs recover, particularly in patients with postoperative voice insufficiency.

Authors+Show Affiliations

Department of Otolaryngology, Tokyo Medical University, Tokyo, Japan; Department of Otolaryngology, International University of Health and Welfare, Mita Hospital, Tokyo, Japan. Electronic address: ujimotokn@hotmail.com.Department of Otolaryngology, International University of Health and Welfare, Mita Hospital, Tokyo, Japan; Tokyo Voice Center, International University of Health and Welfare, Sanno Hospital, Tokyo, Japan.Department of Otolaryngology, International University of Health and Welfare, Mita Hospital, Tokyo, Japan; Tokyo Voice Center, International University of Health and Welfare, Sanno Hospital, Tokyo, Japan.

Pub Type(s)

Comparative Study
Journal Article

Language

eng

PubMed ID

25998408

Citation

Konomi, Ujimoto, et al. "Sex Differences in Pitch Range and Speech Fundamental Frequency After Arytenoid Adduction and Thyroplasty." Journal of Voice : Official Journal of the Voice Foundation, vol. 30, no. 3, 2016, pp. 362-70.
Konomi U, Watanabe Y, Komazawa D. Sex Differences in Pitch Range and Speech Fundamental Frequency After Arytenoid Adduction and Thyroplasty. J Voice. 2016;30(3):362-70.
Konomi, U., Watanabe, Y., & Komazawa, D. (2016). Sex Differences in Pitch Range and Speech Fundamental Frequency After Arytenoid Adduction and Thyroplasty. Journal of Voice : Official Journal of the Voice Foundation, 30(3), 362-70. https://doi.org/10.1016/j.jvoice.2015.03.011
Konomi U, Watanabe Y, Komazawa D. Sex Differences in Pitch Range and Speech Fundamental Frequency After Arytenoid Adduction and Thyroplasty. J Voice. 2016;30(3):362-70. PubMed PMID: 25998408.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Sex Differences in Pitch Range and Speech Fundamental Frequency After Arytenoid Adduction and Thyroplasty. AU - Konomi,Ujimoto, AU - Watanabe,Yusuke, AU - Komazawa,Daigo, Y1 - 2015/05/18/ PY - 2014/11/17/received PY - 2015/03/18/accepted PY - 2015/5/23/entrez PY - 2015/5/23/pubmed PY - 2017/4/26/medline KW - Arytenoid adduction KW - Maximum phonation time KW - Pitch range KW - Sex difference KW - Speech fundamental frequency KW - Thyroplasty KW - Vocal fold paralysis KW - Voice therapy SP - 362 EP - 70 JF - Journal of voice : official journal of the Voice Foundation JO - J Voice VL - 30 IS - 3 N2 - OBJECTIVE: The purpose of this study was to clarify the sex differences in pitch range (PR) and speech fundamental frequency (SFF) after arytenoid adduction (AA) combined with type 1 thyroplasty (TP1) in patients with unilateral vocal fold paralysis (UVFP) and to assess the cause of these differences. STUDY DESIGN: This is a retrospective review of clinical records. METHODS: The records of 50 patients with UVFP for whom PR, SFF, and maximum phonation time (MPT) had been evaluated before and 1 year after AA combined with TP1 were analyzed. Patients consisted of 36 men and 14 women. In particular, in the 37 patients (24 men and 13 women) who had ≥2 semitones (STs) in preoperative PR (pre-PR), the differences and correlations between the pre-PR and the postoperative PR (post-PR), SFF, and MPT were compared between the sexes. We also discussed cases of post-PR deterioration and abnormal SFF. RESULTS: The characteristics of PR in men are narrow pre-PR (14.7 ± 11.5 STs) and significant extension of post-PR (22.6 ± 6.3 STs). MPT extended from 4.6 ± 2.5 seconds to 14.8 ± 7.2 seconds. In contrast, women had a wide pre-PR (18.1 ± 7.2 STs) and showed no significant post-PR extension (21.7 ± 7.8 STs). MPT extended from 5.1 ± 1.9 seconds to 16.8 ± 7.2 seconds. Although there were no significant changes in average SFF, as well as the highest and lowest pitch after the operation, the variance of the pre-SFF tended to converge into the physiological range in the post-SFF (P = 0.08). Compared with the SFF data of normal adult controls, post-SFF in the normal range was 46.0% (23/50). In patients who showed a >20% improvement in PR, normal post-SFF appeared in 68.8% of the patients (11/16). Particularly in those women, 83.3% (5/6) showed a normal post-SFF. Men showed greater difficulty in recovery of normal PR, SFF, and MPT; however, there were fewer patients (4.2%; 1/24) with a PR deterioration of >20%. Regarding women, although some patients showed a parallel recovery in PR and SFF to the normal range, there was a high rate of patients showing PR deterioration (30.8%; 4/13). CONCLUSIONS: AA combined with TP1 resulted in the recovery of not only MPT but also PR and SFF. In addition, sex differences in operative effects were suggested. In men, although MPT is difficult to be fully recovered, PR deterioration was mild. In women, although MPT was more easily extended, PR deterioration occurred more readily because of operative effects such as hypermedialization of their smaller larynx. The post-PR variation appeared to be associated with SFF. Our results indicate the necessity to assess patients' PR and SFF even if their MPTs recover, particularly in patients with postoperative voice insufficiency. SN - 1873-4588 UR - https://www.unboundmedicine.com/medline/citation/25998408/Sex_Differences_in_Pitch_Range_and_Speech_Fundamental_Frequency_After_Arytenoid_Adduction_and_Thyroplasty_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0892-1997(15)00053-3 DB - PRIME DP - Unbound Medicine ER -